The C. diff Returns: The Latest Strategies to Mitigate Recurrence

Target Audience
This activity is intended for ID specialists, hospitalists, internists, pharmacists and other clinicians who care for patients at risk of gastrointestinal infection.

Program Overview
Originally presented at a virtual symposium following IDWeek™ 2020, Paul Feuerstadt, MD, Kevin W. Garey, PharmD, and Krishna Rao, MD, discuss guideline-directed prevention and treatment of recurrent Clostridioides difficile (C. diff). Other discussion topics include risk factors for C. diff recurrence as well as antimicrobial interventions to reduce recurrence and improve outcomes.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Implement tools to identify patients who may be at increased risk for recurrent C. difficile infection
Outline evidence-based approaches for the management of first and second recurrences of C. difficile infection in diverse patient populations
Describe the role of available antimicrobial agents and biologics for treatment and prevention of recurrent C. difficile infection